News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Anagenics.
RELATED STOCKHEAD STORIES
News
Closing Bell: Aussie stocks dive as big miners dig a great hole through Monday
Health & Biotech
Healthy balance sheet with no debt, this overlooked ASX health stock has been paying dividends for years
Health & Biotech
The ASX stocks hoping to profit from the endless search for an ‘elixir of youth’
Health & Biotech
China’s Silk Road for health and wellness is now even more of a two-way street with Australia
Health & Biotech
These are the ASX stocks Morgans thinks can push the health and wellness agenda
Health & Biotech
Check Up: Anteotech riding high with $1.9m refund, and Avecho inks supply agreement for CBD arthritis treatment
News
Reporting Season Round Up: The good times roll on for COVID beneficiary stocks
Health & Biotech
Check Up: Fundie says ‘buy the dip’ as biotech loses shine amid pandemic rebound
Health & Biotech
ASX Health Stocks: M&A winds blow as API gets an upgraded offer from Wesfarmers, jumps 15pc
News
ASX Small Cap Lunch Wrap: Who’s teaming up for defence deals today?
News
10 at 10: These ASX stocks are lifting off this morning
Health & Biotech
Cannabis, medtech, telehealth – could any of these health microcaps be the next multi-bagger?
News
Last Orders: Small caps hit another 12-year high ahead of holiday
Health & Biotech
The health stocks still taking a hit from COVID-19
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
News